FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)

View source ↗

Summary

The FDA approved a supplemental application for Claritin RediTabs (loratadine) submitted by Bayer Healthcare LLC, under the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Claritin RediTabs (Loratadine)

Snippet

SUPPL AP for CLARITIN REDITABS (LORATADINE)